The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...

Compounding Pharmacy Service Market. The Compounding Pharmacy Service market is set to exhibit significant growth, driven by the rising prevalence of chron ...

Plasma-derived therapies are essential for treating a wide range of conditions, including immune deficiencies, bleeding ...

Fresenius to defend itself from FCA suit following whistleblower allegations - A former employee alleges Fresenius engaged in arrangements with hospitals and nephrologists to ensure patient ...

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs. The partnership expands Vifor Pharma’s cooperation with Fresenius ...

In my work and thesis on Fresenius (OTCPK:FSNUF) (OTCPK:FSNUY), I have been clear on my expectations for this company and why I believe it will outperform over time. While the company has taken ...

Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

and pharmaceutical microbiology. Industry experts from Fresenius Kabi will be delivering a spotlight session on day-one of the conference: ‘Contamination Control Elements for Manufacturing Units ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius Kabi related to Fresenius Kabi’s proposed ...

Concurrently, the duo disclosed an asset purchase agreement with Vifor Fresenius Medical Care Renal Pharma (CSL Vifor), a company owned by German dialysis company Fresenius Medical Care (FMS ...

The key players in the U.S. compounding pharmacies market are Avella Specialty Pharmacy, CAPS, Fagron, Fresenius Kabi, and PenCol Pharmacy. Avella Specialty Pharmacy, a prominent player in the ...